Citation: | ZHANG Bin, WU Wei. An Early Onset of Myocardial Infarction Patient with Syphilis and Familial Hypercholesterolemia[J]. Journal of Rare Diseases, 2023, 2(1): 85-87. DOI: 10.12376/j.issn.2097-0501.2023.01.011 |
Syphilis may affect the cardiovascular system, in which coronary arteries are less commonly involved. Familial hypercholesterolemia (FH) is an autosomal dominant inherited disease with elevated low-density lipoprotein-cholesterol (LDL-C) levels due to impaired LDL-C clearance. We report a young male patient with syphilis and FH. The clinical manifestations were acute myocardial infarction and high LDL-C levels. Coronary angiography and intracoronary imaging showed multiple aneurysmal ectasia and stenosis. A drug-eluting stent was implemented when recurrent restenosis occurred after two percutaneous coronary drug-eluting balloon angioplasties.
[1] |
Byard RW. Syphilis-cardiovascular manifestations of the great imitator[J]. J Forensic Sci, 2018, 63(4): 1312-1315. doi: 10.1111/1556-4029.13709
|
[2] |
Yuan SM. Syphilitic aortic aneurysm[J]. Z Rheumatol, 2018, 77(8): 741-748. doi: 10.1007/s00393-018-0519-1
|
[3] |
Nakazone MA, Machado MN, Barbosa RB, et al. Syphilitic coronary artery ostial stenosis resulting in acute myocardial infarction treated by percutaneous coronary intervention[J]. Case Rep Med, 2010, 2010: 830583.
|
[4] |
Kennedy JLW, Barnard JJ, Prahlow JA. Syphilitic coronary artery ostial stenosis resulting in acute myocardial infarction and death[J]. Cardiology, 2006, 105(1): 25-29. doi: 10.1159/000088337
|
[5] |
Jackman JD, Radolf JD. Cardiovascular syphilis[J]. Am J Med, 1989, 87(4): 425-433. doi: 10.1016/S0002-9343(89)80826-5
|
[6] |
Devabhaktuni S, Mercedes A, Diep J, et al. Coronary artery ectasia-a review of current literature[J]. Curr Cardiol Rev, 2016, 12(4): 318-323. doi: 10.2174/1573403X12666160504100159
|
[7] |
Zhang L, Wang Y, Zhang Z, et al. Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study[J]. BMC Cardiovasc Disord, 2021, 21(1): 438. doi: 10.1186/s12872-021-02245-6
|
[8] |
McGowan MP, Hosseini Dehkordi SH, Moriarty PM, et al. Diagnosis and treatment of heterozygous familial hypercholesterolemia[J]. J Am Heart Assoc, 2019, 8(24): e013225. doi: 10.1161/JAHA.119.013225
|
[9] |
Defesche JC, Gidding SS, Harada-Shiba M, et al. Familial hypercholesterolaemia[J]. Nat Rev Dis Primers, 2017, 3(1): 17093. doi: 10.1038/nrdp.2017.93
|
[10] |
Kastelein JJP, Reeskamp LF, Hovingh GK. Familial hypercholesterolemia[J]. J Am Coll Cardiol, 2020, 75(20): 2567-2569. doi: 10.1016/j.jacc.2020.03.058
|